Cargando…
Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach
On January 20, 2020, the first patient with coronavirus disease 2019 (COVID-19) in the United States of America was diagnosed in Washington state, which subsequently experienced rapidly increasing numbers of COVID-19 cases, hospitalizations, and deaths. This placed the Seattle Blood and Marrow Trans...
Autores principales: | Ueda Oshima, Masumi, Sandmaier, Brenda M., Petersdorf, Effie, Flowers, Mary E., Hill, Geoffrey R., Lee, Stephanie J., Appelbaum, Frederick R., Carpenter, Paul A., Baker, K. Scott, Connelly-Smith, Laura, McCool, Andrea, Elgar, Suni, Pergam, Steven A., Liu, Catherine, Stewart, F. Marc, Mielcarek, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519858/ https://www.ncbi.nlm.nih.gov/pubmed/32980860 http://dx.doi.org/10.1038/s41409-020-01068-x |
Ejemplares similares
-
Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation
por: Ueda Oshima, Masumi, et al.
Publicado: (2023) -
The World Marrow Donor Association: Twenty Years of International Collaboration for the Support of Unrelated Donor and Cord Blood Hematopoietic Cell Transplantation
por: Petersdorf, Effie W.
Publicado: (2010) -
Multidrug-Resistant Bacteroides fragilis — Seattle, Washington, 2013
por: Kalapila, Aley, et al.
Publicado: (2013) -
Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
por: Rashidi, Armin, et al.
Publicado: (2023) -
Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation
por: Fatobene, Giancarlo, et al.
Publicado: (2019)